DCF — CITY OF HOPE NATIONAL MEDICAL CTR
Enterprise Value: $-3.1B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-3.1B
Enterprise Value
$-974.7M
PV of Cash Flows
$-2.1B
PV of Terminal Value
$-3.4B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.9B | $-193.1M | -10.0% | $-272.9M | $-248.1M |
| Year 2 | $1.9B | $-179.5M | -9.0% | $-261.7M | $-216.2M |
| Year 3 | $2.0B | $-164.9M | -8.0% | $-249.5M | $-187.5M |
| Year 4 | $2.1B | $-159.5M | -8.0% | $-246.7M | $-168.5M |
| Year 5 | $2.1B | $-159.0M | -7.0% | $-248.8M | $-154.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-3.1B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.8B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.10746980320398919
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5